Category Archives: Biotechnology

BENGALURU: For all Bioscience graduates pursuing BE, BTech, BSc, MSc, MTech and PhD courses, there is good news for their career. The department of Biotechnology at Sir M Visvesvaraya Institute of Tecnology (MVIT) is organising a three day national seminar on Entrepreneurial Opportunities in Biotechnology from March 23 - 25 at its campus. The seminar that is also open to inquisitive parents, energetic alumni, enthusiastic faculty and industry experts is expected to alleviate the many concerns of graduates and their parents regarding their future prospects and career development. HG Nagendra, professor and head of the Biotechnology department, said: "The focus of education is to not only train the students in curriculum defined skillsets but also to guide them towards realising their higher aspirations." The seminar includes invited plenary talks by subject experts, panel discussions, industry-academia interactive sessions, poster sessions, project idea presentations, several stalls and displays. Cash awards will be awarded to those with best presentations and networking at the seminar. Read the original: MVIT organises three-day national seminar on Biotechnology - Times of India … Continue reading →

Dr S Balasubramanya, BTFS Coordinator and Dr Mittur N Jagadish, Head-BioTech Facilitation Cell, KBITS, Government of Karnataka Karnataka state has remained one of the major investment destinations in the biotech industry. Currently, the State of Karnataka contributes around 35 per cent of the Indian biotechnology sector. The state government has established Biotechnology Bio-Innovation Centre at Bengaluru Helix. Theme-based biotech parks are at various stages of implementation in Bidar, Dharwad, Mangaluru and Mysuru. The state has already in place, multi-sector start-up policy with various industry specific incentives and ease of doing business measures to stimulate growth of industry in Karnataka. Life Sciences Sector Skill Development Council (LSSSDC) has estimated life sciences industry which includes biotechnology industry to employ 1.5-1.6 million people by 2020. The sector is expected to see a possible supply gap upwards of 0.3-0.4 million, with the highest gap in the manufacturing segment. The majority of full-time employees are distributed between marketing and manufacturing, and a limited number in R&D and other functions. Approximately, 40 per cent job roles are clustered at entry/junior level; 35 per cent at mid-level and 20 per cent at senior levels in the industry. The junior and entry level positions that make up 40 … Continue reading →

iShares NASDAQ Biotechnology Index (IBB) Announces Quarterly Dividend of $0.30 The Cerbat Gem iShares NASDAQ Biotechnology Index logo iShares NASDAQ Biotechnology Index (NASDAQ:IBB) announced a quarterly dividend on Friday, March 24th. Investors of record on Tuesday, March 28th will be paid a dividend of 0.299 per share on Thursday, ... and more » See more here: iShares NASDAQ Biotechnology Index (IBB) Announces Quarterly Dividend of $0.30 - The Cerbat Gem … Continue reading →

PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Changes in Registrant's Certifying Accountant Market Exclusive Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the global development and commercialization rights to over ... Read the original: PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI) Files An 8-K Changes in Registrant's Certifying Accountant - Market Exclusive … Continue reading →

The Indian Express CEEB 2017: Applications released for MSc, MTech Biotechnology courses, check here The Indian Express CEEB 2017: The Jawaharlal Nehru University (JNU), Delhi has announced that it will hold The Combined Entrance Examination (CEEB) 2017 for MSc in Biology, MSc in Agricultural Biotechnology and MTech in Biotechnology will be held on May 19, 2017. Here is the original post: CEEB 2017: Applications released for MSc, MTech Biotechnology courses, check here - The Indian Express … Continue reading →

Dr Kalpana Joshi shares her thoughts with BioSpectrum on current biotech education and the academia-industry gap Dr Kalpana Joshi is Professor and Head of the Department of Biotechnology at Sinhgad College of Engineering (SCOE). The institute is affiliated to Savitribai Phule Pune University (SPPU) and recognised by All India Council for Technical Education (AICTE), New Delhi. Recently, SCOE has received NAAC "A" Grade. BTech Biotechnology course run by the department is first AICTE approved course in SPPU. Dr Joshi completed her doctorate in molecular biology from National Chemical Laboratory. She headed in-vitro biology group at Pharma R and D, besides giving consultancy to pharma companies like Glenmark, Matrix, Hyderabad and Orchids, Chennai. The SCOE department has a team of faculty with expertise in fermentation engineering, biochemical engineering, pharma biotechnology, biochemistry, analytical chemistry and microbiology. Faculty is active in fetching grants for research, patents and publications. Dr Joshi shares her thoughts with BioSpectrum on current biotech education and the academia-industry gap Do you think biotech schools are teaching what industry needs? Field of biotechnology is ever expanding and evolving. Pharma companies have diversified into production and business of biotherapeutics, vaccines and immunologicals, and molecular diagnostics. Industries such as agri-biotech, dairy biotech, … Continue reading →

OTTAWA, Ontario--(BUSINESS WIRE)-- Canada's biotech industry today welcomed the federal budget and its measures supporting the advancement of Canadian innovation in biotechnology centered sectors such as health/bio-sciences, clean technology and agri-food. Importantly the budget proposes support for the acceleration of innovation through the establishment of sector specific superclusters, including health/bio-sciences, agri-food and clean technology. "The core of our industry is innovation - much of it coming out of universities. The Budgets focus on innovation and creating super clusters in biotechnology centered fields including health/bio-sciences, agri-food, and clean technology recognizes Canadas strengths in these areas and the enormous opportunity for the economy in successfully advancing biotechnology innovation. Today's commitments will result in products and therapies of the future and will accelerate the use of biotechnology in supporting the global competitiveness of Canadas traditional cornerstone economic sectors of agriculture, forestry, mining, energy and advanced manufacturing," commented Andrew Casey, President and CEO BIOTECanada. Drawing on the nation's rich legacy of research, Canada now has an opportunity to become one of the worlds most successful modern biotech regions by transitioning its traditional industries into the new economy while drawing on its considerable strength of its investment in research. From universities, small mid-sized companies, hospitals … Continue reading →

Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results P&T Community TEL AVIV, Israel, March 23, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and ... and more » Read more from the original source: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results - P&T Community … Continue reading →

The Technical Facts on Puma Biotechnology, Inc. (PBYI) The USA Commerce We have gathered the technical data on Puma Biotechnology, Inc. (PBYI), and see some interesting trends in the stock's behavior of late. They say the soul of a stock is best known by an examination of its behavior on the tape. With that in mind ... and more » Read the original here: The Technical Facts on Puma Biotechnology, Inc. (PBYI) - The USA Commerce … Continue reading →

CHICAGO--(BUSINESS WIRE)-- The Illinois Biotechnology Innovation Organization (iBIO) today announced the keynote panel for the 2017 iBIO Industry Exposition (iBIO IndEx), held in Rosemont, Illinois, April 24, 2017. The theme of this year's iBIO IndEx, is Converge to Emerge. TheiBIO IndEx 2017 is a place to connect with more than 500 key thought leaders and peers from diverse backgrounds, and gather insight to help drive industry-wide growth and transformation in Illinois. iBIO's signature event is a forum to discuss the latest trends and innovations impacting our community. We are excited to announce the first keynote panel for the 2017 iBIO IndEx, said Warren Ribley, iBIO president and CEO. We are very fortunate this year to have a strong lineup of industry leaders from our community. Attendees can expect to learn how the biopharma community is focusing on innovative lifesaving medicines while navigating a changing regulatory and political landscape. The four keynote panelists are: "Thanks to the tireless work of biopharmaceutical researchers and scientists, we have entered a new era of medicine that is transforming the way we treat and cure diseases, said Stephen Ubl, president and CEO PhRMA . "The iBIO IndEx is an opportunity to convene with other industry … Continue reading →